A detailed history of Alesco Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alesco Advisors LLC holds 270 shares of LLY stock, worth $214,995. This represents 0.01% of its overall portfolio holdings.

Number of Shares
270
Previous 268 0.75%
Holding current value
$214,995
Previous $242,000 1.24%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $1,544 - $1,920
2 Added 0.75%
270 $239,000
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $194,265 - $243,622
268 New
268 $242,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alesco Advisors LLC Portfolio

Follow Alesco Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alesco Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alesco Advisors LLC with notifications on news.